Neumonía por Pneumocystis jirovecii posterior a COVID-19 en un paciente sin infección por VIH
Amparo-Vicente, María; Morte, Elena.
Rev. chil. infectol
; 39(3): 357-360, jun. 2022. ilus
Artículo en Español | LILACS | ID: biblio-1407790
Documentos relacionados
A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital.
Outcomes and factors contributing to poor prognosis of Pneumocystis jirovecii pneumonia in HIV-negative patients: a cross-sectional retrospective study in a Chinese single center.
Low cut-off value of serum (1,3)-beta-D-glucan for the diagnosis of Pneumocystis pneumonia in non-HIV patients: a retrospective cohort study.
Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention.
Unique presentation of late-onset Pneumocystis pneumonia in a pediatric kidney transplant recipient.
Alternative pneumocystis prophylaxis in solid organ transplant recipients at two large transplant centers.
Unusual Presentation of <i>Pneumocystis jirovecii</i> Pneumonia in an Immunocompromised Host.
Extrapulmonary Pneumocystis jirovecii infection in an advanced HIV-infected patient: A case report and literature review.
Extracorporeal membrane oxygenation rescue for severe pneumocystis pneumonia with the Macklin effect: a case report.
Clinical characteristics and risk factor analysis of Pneumocystis jirovecii pneumonia in patients with CKD: a machine learning-based approach.